
Future Positive Capital
Description
Future Positive Capital is a Paris-based venture capital firm dedicated to investing in deep technology companies that aim to generate significant positive societal and environmental impact. Co-founded by Alexandre Vellin and Michael Baum, the firm distinguishes itself by backing startups that leverage cutting-edge scientific and engineering breakthroughs to address some of the world's most pressing challenges. Their investment philosophy is rooted in the belief that technological innovation, when guided by a strong ethical compass, can be a powerful force for good.
The firm primarily targets Seed and Series A stage companies across a diverse range of deep tech sectors. These include artificial intelligence, biotechnology, new materials, robotics, space technology, quantum computing, and climate tech. Future Positive Capital seeks out founders who are not only building groundbreaking technologies but are also deeply committed to creating solutions with measurable positive outcomes, aligning financial returns with a broader mission of global betterment.
Future Positive Capital successfully closed its inaugural fund, Fund I, at €100 million in October 2023, demonstrating strong investor confidence in their impact-driven deep tech strategy. From this fund, the firm has already made approximately 18 investments, supporting a portfolio of innovative companies. They typically deploy first cheques ranging from €500,000 to €5 million, which translates to approximately $540,000 to $5,400,000 USD, depending on the prevailing exchange rates. This strategic capital deployment enables them to support early-stage ventures through critical development phases, helping them scale their technologies and amplify their positive impact on the world.
Investor Profile
Future Positive Capital has backed more than 25 startups, with 4 new investments in the last 12 months alone. The firm has led 7 rounds, about 28% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series B rounds (top funding stages).
- Majority of deals are located in United Kingdom, France, United States.
- Strong thematic focus on Artificial Intelligence (AI), Machine Learning, Health Care.
- Led 1 rounds in the past year.
- Typical check size: $540K – $5.4M.
Stage Focus
- Series A (36%)
- Seed (24%)
- Series B (16%)
- Series Unknown (16%)
- Convertible Note (4%)
- Series C (4%)
Country Focus
- United Kingdom (36%)
- France (24%)
- United States (16%)
- Belgium (12%)
- Germany (8%)
- The Netherlands (4%)
Industry Focus
- Artificial Intelligence (Ai)
- Machine Learning
- Health Care
- Biotechnology
- Medical
- Cleantech
- Energy
- Natural Resources
- Software
- Electric Vehicle
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.